Percentages of KJ1-26+/CD25+ and KJ1-26+/CTLA-4+ cells among CD4+T cells 8 days after injection of αDEC-OVA and G1117-OVA, respectively
. | αDEC-OVA—injected mice . | . | G1117-OVA—injected mice . | . | ||
|---|---|---|---|---|---|---|
| Experiment no. . | % CD25 . | % CTLA-4 . | % CD25 . | % CTLA-4 . | ||
| 1 | 0.40 | 0.30 | 0.10 | 0.10 | ||
| 2 | 0.50 | 0.30 | 0.20 | 0.10 | ||
| 3 | 0.80 | 0.60 | 0.10 | 0.00 | ||
| 4 | 0.30 | 0.30 | 0.00 | 0.00 | ||
| Mean ± SD | 0.50 ± 0.19 | 0.38 ± 13 | 0.10 ± 0.07 | 0.05 ± 0.05 | ||
. | αDEC-OVA—injected mice . | . | G1117-OVA—injected mice . | . | ||
|---|---|---|---|---|---|---|
| Experiment no. . | % CD25 . | % CTLA-4 . | % CD25 . | % CTLA-4 . | ||
| 1 | 0.40 | 0.30 | 0.10 | 0.10 | ||
| 2 | 0.50 | 0.30 | 0.20 | 0.10 | ||
| 3 | 0.80 | 0.60 | 0.10 | 0.00 | ||
| 4 | 0.30 | 0.30 | 0.00 | 0.00 | ||
| Mean ± SD | 0.50 ± 0.19 | 0.38 ± 13 | 0.10 ± 0.07 | 0.05 ± 0.05 | ||
Data represent mean ± SD.